Epizyme, Inc.

Epizyme, Inc.verified

EPZM

Price:

$1.47

Market Cap:

$0

Epizyme, Inc., a commercial-stage biopharmaceutical company, discovers, develops, and commercializes novel epigenetic medicines for patients with cancer and other diseases in the United States. The company offers Tazemetostat for the treatment of metastatic or locally advanced epithelioid sarcoma for adults and pediatric patients. It also develops R-CHOP in front-line patients with high risk diffuse large B-cell lymphoma; and PARP inhibitor in patients with PARPi-resistant solid tumors, such as castration-resistant prostate cancer, small cell lung cancer, and others. In addition, the company develops Tazemetostat in patients with INI1-negative tumors in adults and pediatrics; PRMT5 inhibitor...[Read more]

Industry

Biotechnology

IPO Date

2013-05-31

Stock Exchange

NASDAQ

Ticker

EPZM

The Current Ratio as of December 2025 (TTM) for Epizyme, Inc. (EPZM) is 4.56

According to Epizyme, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.56. This represents a change of -14.42% compared to the average of 5.33 of the last 4 quarters.

Epizyme, Inc. (EPZM) Historical Current Ratio (quarterly & annually)

How has EPZM Current Ratio performed in the past?

The mean historical Current Ratio of Epizyme, Inc. over the last ten years is 8.62. The current 4.56 Current Ratio has changed 5.19% with respect to the historical average. Over the past ten years (40 quarters), EPZM's Current Ratio was at its highest in in the March 2016 quarter at 22.79. The Current Ratio was at its lowest in in the September 2012 quarter at 0.

Quarterly (TTM)
Annual

Average

8.62

Median

10.39

Minimum

2.83

Maximum

11.61

Epizyme, Inc. (EPZM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Epizyme, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 147.76%

Maximum Annual Current Ratio = 11.61

Minimum Annual Increase = -51.16%

Minimum Annual Current Ratio = 2.83

Quarterly (TTM)
Annual
YearCurrent RatioChange
20214.56-51.16%
20209.33-19.60%
201911.6161.15%
20187.20-37.83%
201711.590.75%
201611.50-0.41%
201511.550.94%
201411.44147.76%
20134.6262.93%
20122.83-9.20%

Epizyme, Inc. (EPZM) Average Current Ratio

How has EPZM Current Ratio performed in the past?

The current Current Ratio of Epizyme, Inc. (EPZM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

8.50

5-year avg

8.86

10-year avg

8.62

Epizyme, Inc. (EPZM) Current Ratio vs. Peers

How is EPZM’s Current Ratio compared to its peers?

Epizyme, Inc.’s Current Ratio is less than Acelyrin, Inc. (18.43), less than CARGO Therapeutics, Inc. Common Stock (12.37), less than Third Harmonic Bio, Inc. (54.10), greater than Inozyme Pharma, Inc. (2.19), greater than Celularity Inc. (0.16), less than Catabasis Pharmaceuticals, Inc. (14.89), greater than Spectrum Pharmaceuticals, Inc. (2.37), less than 2seventy bio, Inc. (4.80), greater than Alaunos Therapeutics, Inc. (2.92), greater than Inhibrx Biosciences, Inc. (4.49),

Build a custom stock screener for Epizyme, Inc. (EPZM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Epizyme, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Epizyme, Inc. (EPZM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Epizyme, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Epizyme, Inc.'s Current Ratio?

How is the Current Ratio calculated for Epizyme, Inc. (EPZM)?

What is the highest Current Ratio for Epizyme, Inc. (EPZM)?

What is the 3-year average Current Ratio for Epizyme, Inc. (EPZM)?

What is the 5-year average Current Ratio for Epizyme, Inc. (EPZM)?

How does the current Current Ratio for Epizyme, Inc. (EPZM) compare to its historical average?